> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Xenotransplantation Regulatory Issues
- URL: https://www.fdaweb.com/panel-to-discuss-xenotransplantation-regulatory-issues/
- Published: 2022-05-31T12:00:00.000Z
- Updated: 2026-09-14T17:46:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151939

*Federal Register* notice: FDA has announced a 6/30 Cellular, Tissue, and Gene Therapies Advisory Committee meeting. Panel members are scheduled to discuss the current regulatory expectations for xenotransplantation products, including human cells that have had ex vivo contact with animal cells, and animal organs and cells for transplantation into human subjects. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-05-31/pdf/2022-11563.pdf?ref=fdaweb.com).